Crossmark

Identifining a Therapeutic Window for Intranasal Insulin Administration in a Two-Vessel Rat Model of Forebrain Ischemia and Investigating the Mechanisms of Its Neuroprotective Action

Crossref DOI link: https://doi.org/10.1134/S0022093025030056

Published Online: 2025-07-11

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zorina, I. I.

Pechalnova, A. S.

Chernenko, E. E.

Avrova, D. K.

Derkach, K. V.

Shpakov, A. O.
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 1 April 2025

Revised: 22 April 2025

Accepted: 24 April 2025

First Online: 11 July 2025

ETHICS APPROVAL

: Animal-related experiments were carried out in compliance with the NIH Guidelines for the care and use of laboratory animals (http://oacu.od.nih.gov/regs/index.htm), as well as the requirements of the Basel Declaration and legal acts of the Russian Federation. Experimental protocols were approved by the Ethics Committee of IEPhB RAS (Minutes no. 7, of August 10, 2021). (Minutes no. 8-1/2023, Meeting no. 8 of August 24, 2023).

: The authors of this work declare that they have no conflict of interest.

Document is current

Any future updates will be listed below